From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA grants orphan drug status for congenital ichthyosis treatment

from Dermatology Times

The Food and Drug Administration has granted orphan drug designation to Galderma’s trifarotene molecule for the treatment of congenital ichthyosis. As a result, Galderma officials say the company plans to implement a clinical development plan to explore new treatment options for other rare skin diseases such as cutaneous T-cell lymphoma and Gorlin syndrome. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063